Production (Stage)
Immunic, Inc.
IMUX
$0.8673
$0.078910.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 31.84% | -7.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.66% | -0.37% | |||
| Operating Income | -4.66% | 0.37% | |||
| Income Before Tax | -1.18% | -3.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.18% | -3.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.18% | -3.31% | |||
| EBIT | -4.66% | 0.37% | |||
| EBITDA | -4.63% | 0.34% | |||
| EPS Basic | -0.56% | -3.91% | |||
| Normalized Basic EPS | 6.15% | -3.86% | |||
| EPS Diluted | -0.56% | -3.91% | |||
| Normalized Diluted EPS | 6.15% | -3.86% | |||
| Average Basic Shares Outstanding | 0.64% | -0.56% | |||
| Average Diluted Shares Outstanding | 0.64% | -0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||